Posts filtered by tags: Benjamin Rome[x]


Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients

New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs—at least for some patients. This is counter to a common industry claim that patients aren’t affected by list price increases. The study found a link between list prices rising and out-of-pocket…Read more...
Tags: Health, Science, Medicare, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Pharmacy, Pharmaceutical Industry, Drug Pricing, Prescription drug, Health Sciences, U S Healthcare, Healthcare Reform In The United States, Pharmaceuticals Policy, Health Medical Pharma, Benjamin Rome

Original investigation: When drug companies raise list prices, out-of-pocket costs for patients

A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division of Pharmacoepidemiology and Pharmacoeconomics finds that more than half of patients may experience increases in out-of-pocket spending when drug prices increase.
Tags: Science, Benjamin Rome